These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 32408259)

  • 1. Brain uptake and accumulation of new levofloxacin-doxycycline combination through the use of solid lipid nanoparticles: Formulation; Optimization and in-vivo evaluation.
    Abdel Hady M; Sayed OM; Akl MA
    Colloids Surf B Biointerfaces; 2020 Sep; 193():111076. PubMed ID: 32408259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranasal agomelatine solid lipid nanoparticles to enhance brain delivery: formulation, optimization and in vivo pharmacokinetics.
    Fatouh AM; Elshafeey AH; Abdelbary A
    Drug Des Devel Ther; 2017; 11():1815-1825. PubMed ID: 28684900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of Box-Behnken design for preparation of levofloxacin-loaded stearic acid solid lipid nanoparticles for ocular delivery: Optimization, in vitro release, ocular tolerance, and antibacterial activity.
    Baig MS; Ahad A; Aslam M; Imam SS; Aqil M; Ali A
    Int J Biol Macromol; 2016 Apr; 85():258-70. PubMed ID: 26740466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid nanoparticles of zaleplon for improved oral delivery by Box-Behnken design: optimization, in vitro and in vivo evaluation.
    Dudhipala N; Janga KY
    Drug Dev Ind Pharm; 2017 Jul; 43(7):1205-1214. PubMed ID: 28274147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel nasal almotriptan loaded solid lipid nanoparticles in mucoadhesive in situ gel formulation for brain targeting: Preparation, characterization and in vivo evaluation.
    Youssef NAHA; Kassem AA; Farid RM; Ismail FA; El-Massik MAE; Boraie NA
    Int J Pharm; 2018 Sep; 548(1):609-624. PubMed ID: 30033394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation and optimization of intranasal nanolipid carriers of pioglitazone for the repurposing in Alzheimer's disease using Box-Behnken design.
    Jojo GM; Kuppusamy G; De A; Karri VVSNR
    Drug Dev Ind Pharm; 2019 Jul; 45(7):1061-1072. PubMed ID: 30922126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repaglinide-Solid Lipid Nanoparticles in Chitosan Patches for Transdermal Application: Box-Behnken Design, Characterization, and In Vivo Evaluation.
    Ali HSM; Namazi N; Elbadawy HM; El-Sayed AAA; Ahmed SA; Bafail R; Almikhlafi MA; Alahmadi YM
    Int J Nanomedicine; 2024; 19():209-230. PubMed ID: 38223883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced Brain Delivery
    Arya RKK; Vijay J; Bisht D; Rashid M; Alfawaz Altamimi AS; Afzal O; Sethiya NK
    Curr Drug Deliv; 2023; 20(5):587-600. PubMed ID: 35598246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, optimization and pharmacokinetic evaluation of Piribedil loaded solid lipid nanoparticles dispersed in nasal in situ gelling system for effective management of Parkinson's disease.
    Uppuluri CT; Ravi PR; Dalvi AV
    Int J Pharm; 2021 Sep; 606():120881. PubMed ID: 34273426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development, Optimization, and Evaluation of Carvedilol-Loaded Solid Lipid Nanoparticles for Intranasal Drug Delivery.
    Aboud HM; El Komy MH; Ali AA; El Menshawe SF; Abd Elbary A
    AAPS PharmSciTech; 2016 Dec; 17(6):1353-1365. PubMed ID: 26743643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization by design of etoposide loaded solid lipid nanoparticles for ocular delivery: Characterization, pharmacokinetic and deposition study.
    Ahmad I; Pandit J; Sultana Y; Mishra AK; Hazari PP; Aqil M
    Mater Sci Eng C Mater Biol Appl; 2019 Jul; 100():959-970. PubMed ID: 30948132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Application of Box-Behnken design for optimization and development of quetiapine fumarate loaded chitosan nanoparticles for brain delivery via intranasal route* ".
    Shah B; Khunt D; Misra M; Padh H
    Int J Biol Macromol; 2016 Aug; 89():206-18. PubMed ID: 27130654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization of Nanostructured Lipid Carriers of Lurasidone Hydrochloride Using Box-Behnken Design for Brain Targeting: In Vitro and In Vivo Studies.
    Jazuli I; Annu ; Nabi B; Moolakkadath T; Alam T; Baboota S; Ali J
    J Pharm Sci; 2019 Sep; 108(9):3082-3090. PubMed ID: 31077685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solid Lipid Nanoparticles Approach for Lymphatic Targeting Through Intraduodenal Delivery of Quetiapine Fumarate.
    Yasir M; Gaur PK; Puri D; Shehkar P; Kumar SS
    Curr Drug Deliv; 2018; 15(6):818-828. PubMed ID: 28545354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain Targeting of Temozolomide via the Intranasal Route Using Lipid-Based Nanoparticles: Brain Pharmacokinetic and Scintigraphic Analyses.
    Khan A; Imam SS; Aqil M; Ahad A; Sultana Y; Ali A; Khan K
    Mol Pharm; 2016 Nov; 13(11):3773-3782. PubMed ID: 27661966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nose-to-brain delivery of sumatriptan-loaded nanostructured lipid carriers: preparation, optimization, characterization and pharmacokinetic evaluation.
    Masjedi M; Azadi A; Heidari R; Mohammadi-Samani S
    J Pharm Pharmacol; 2020 Oct; 72(10):1341-1351. PubMed ID: 32579251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smart lipid nanoparticles containing levofloxacin and DNase for lung delivery. Design and characterization.
    Islan GA; Tornello PC; Abraham GA; Duran N; Castro GR
    Colloids Surf B Biointerfaces; 2016 Jul; 143():168-176. PubMed ID: 27003467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Part I: Development and optimization of solid-lipid nanoparticles using Box-Behnken statistical design for ocular delivery of gatifloxacin.
    Abul Kalam M; Sultana Y; Ali A; Aqil M; Mishra AK; Aljuffali IA; Alshamsan A
    J Biomed Mater Res A; 2013 Jun; 101(6):1813-27. PubMed ID: 23255511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of quality by design approach for intranasal delivery of rivastigmine loaded solid lipid nanoparticles: Effect on formulation and characterization parameters.
    Shah B; Khunt D; Bhatt H; Misra M; Padh H
    Eur J Pharm Sci; 2015 Oct; 78():54-66. PubMed ID: 26143262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nose-To-Brain Delivery of PLGA-Diazepam Nanoparticles.
    Sharma D; Sharma RK; Sharma N; Gabrani R; Sharma SK; Ali J; Dang S
    AAPS PharmSciTech; 2015 Oct; 16(5):1108-21. PubMed ID: 25698083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.